ArticleClinical rheumatology2026
Clinical indicators associated with pericardial effusion in rheumatoid arthritis: a machine learning-based analysis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPericardial effusion (PE) is a frequent yet underdiagnosed complication of rheumatoid arthritis (RA), with substantial mortality risk. Nevertheless, early detection remains challenging due to nonspecific presentations and the limited feasibility of routine echocardiography. We aimed to identify simple clinical and laboratory features associated with the presence of PE using advanced machine learning (ML) approaches.
methodsIn this cross-sectional study, 958 RA patients were evaluated, all of whom underwent transthoracic echocardiography for PE detection. A comprehensive set of demographic, clinical, and laboratory variables was analyzed. Eight ML algorithms were developed and evaluated using 45 repeated train-test splits to enhance robustness. Model performance was assessed using area under the precision-recall curve (AUC-PR) and receiver operating characteristic curve (AUC-ROC). Feature importance was determined using SHAP analysis.
resultsPE was present in 126 patients (13.2%). The random forest (RF) model achieved the best performance (mean AUC-PR, 0.674 [95% CI 0.504-0.824]; mean AUC-ROC, 0.943 [95% CI 0.903-0.968]). The most influential features were palpitation, chest pain, RA disease duration, and age. Patients with PE were older (62.8 ± 12.15 vs. 57.7 ± 12.65 years, p ≤ 0.001), and several clinical features differed significantly between groups (p < 0.05). SHAP analysis demonstrated a consistent positive association of palpitation, chest pain, longer disease duration, and older age with PE detection.
conclusionThese findings support the use of readily available clinical features by ML to increase diagnostic suspicion for PE in patients with RA. RA patients presenting with palpitations or chest pain, particularly those of older age or with long-standing disease, may warrant closer consideration for echocardiographic evaluation. Key Points • Pericardial effusion is a common yet often underrecognized and potentially life-threatening complication in patients with rheumatoid arthritis. • This study is the first to apply machine learning techniques to identify simple clinical and laboratory indicators associated with pericardial effusion in rheumatoid arthritis. • Palpitation, chest pain, older age, and longer disease duration were identified as the clinical features most strongly associated with the presence of pericardial effusion. • These findings may help clinicians identify patients in whom suspicion for pericardial effusion should be heightened and echocardiographic evaluation more strongly considered.
Indexed as
Identifiers
42236651What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.